1. Predicting the Likelihood of Carrying a
- Author
-
Boon Hong, Ang, Weang Kee, Ho, Eldarina, Wijaya, Pui Yoke, Kwan, Pei Sze, Ng, Sook Yee, Yoon, Siti Norhidayu, Hasan, Joanna M C, Lim, Tiara, Hassan, Mei-Chee, Tai, Jamie, Allen, Andrew, Lee, Nur Aishah Mohd, Taib, Cheng Har, Yip, Mikael, Hartman, Swee Ho, Lim, Ern Yu, Tan, Benita K T, Tan, Su-Ming, Tan, Veronique K M, Tan, Peh Joo, Ho, Alexis J, Khng, Alison M, Dunning, Jingmei, Li, Douglas F, Easton, Antonis C, Antoniou, and Soo Hwang, Teo
- Subjects
BRCA2 Protein ,Ovarian Neoplasms ,Cross-Sectional Studies ,BRCA1 Protein ,Genes, BRCA2 ,Mutation ,Humans ,Breast Neoplasms ,Female ,Genetic Predisposition to Disease ,Middle Aged ,Germ-Line Mutation - Abstract
With the development of poly (ADP-ribose) polymerase inhibitors for treatment of patients with cancer with an alteredIn this study, we built a new model (Asian Risk Calculator) for estimating the likelihood of carrying a pathogenic variant inAsian Risk Calculator included age of diagnosis, ethnicity, bilateral breast cancer, tumor biomarkers, and family history of breast cancer or ovarian cancer as predictors. The inclusion of tumor grade improved significantly the model performance. The full model was calibrated (Hosmer-LemeshowPopulation-specific customization of mutation prediction models and clinical genetic testing criteria improved the accuracy of BRCA mutation prediction in Asian patients.
- Published
- 2022